论文信息 - Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a–Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders - 字舞流文

Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a–Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders

R. Petric | E. Gane | D. Larrey | P. N. Morcos | Patrick F. Smith | S. Le Pogam | I. Nájera | B. Brennan | N. Shulman | Ying Zhang | R. Rouzier | J. Q. Tran | Ellen S. Yetzer | R. Kulkarni | A. Wiercińska-Drapało | Rohit N. Kulkarni